Literature DB >> 16777151

Energy balance and food intake: the role of PPARgamma gene polymorphisms.

Joanne E Cecil1, Peter Watt, Colin N Palmer, Marion Hetherington.   

Abstract

Mechanisms regulating energy balance involve complex interactions between genetic, environmental and behavioural (learnt and intrinsic) factors. Genotype may drive the partitioning of energy metabolism and predispose to site-specific adiposity, culminating in a state of energy imbalance. One candidate gene with a direct link to adiposity is the peroxisome proliferator-activated receptor gamma (PPARG) gene. PPARG is a cell nuclear receptor expressed almost exclusively in adipose tissue that regulates adipocyte differentiation, lipid metabolism and insulin sensitivity. PPARgamma appears to be a key regulator of energy balance, with polymorphisms on the PPARG gene linked to obesity and effects on body composition. Our research has confirmed an association between the pro12ala allele and reduced incidence of obesity in pre-pubertal children and there are strong associations between genetic variation at the PPARG locus and percentage body fat. Moreover, our evidence suggests that PPARG C-681G and pro12ala polymorphisms display opposing effects in terms of growth phenotype, with pro12Ala associated with deficient energy utilisation, leading to reduced growth and the G-681 variant associated with accelerated growth compared with wildtypes. Common differences in this gene have also been associated with variations in body weight in response to dietary macronutrients. Preliminary evidence suggests that PPARG variants may even be involved in the control of short term energy compensation. Taken together these data suggest that the role of PPARG is varied and complex, influencing fat deposition and growth velocity early in life, with potential impact in the control of energy intake and appetite regulation, and could provide a key target for future research and anti-obesity agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777151     DOI: 10.1016/j.physbeh.2006.05.028

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  14 in total

Review 1.  Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease.

Authors:  Juanita L Merchant
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  PPAR-γ action: it's all in your head.

Authors:  Martin G Myers; Charles F Burant
Journal:  Nat Med       Date:  2011-05       Impact factor: 53.440

3.  Relationship between expression and methylation of obesity-related genes in children.

Authors:  Veronica Davé; Paul Yousefi; Karen Huen; Vitaly Volberg; Nina Holland
Journal:  Mutagenesis       Date:  2015-01-14       Impact factor: 3.000

4.  Gender, body mass index, and PPARγ polymorphism are good indicators in hyperuricemia prediction for Han Chinese.

Authors:  Ming-Fen Lee; Tsan-Hon Liou; Weu Wang; Wen-Harn Pan; Wei-Jei Lee; Chung-Tan Hsu; Suh-Fen Wu; Hsin-Hung Chen
Journal:  Genet Test Mol Biomarkers       Date:  2013-01

5.  Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice.

Authors:  Galyna Bryzgalova; Lovisa Lundholm; Neil Portwood; Jan-Ake Gustafsson; Akhtar Khan; Suad Efendic; Karin Dahlman-Wright
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-12       Impact factor: 4.310

6.  The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity.

Authors:  Panayotis K Thanos; Michael Michaelides; Christopher W Ho; Gene-Jack Wang; Amy H Newman; Christian A Heidbreder; Charles R Ashby; Eliot L Gardner; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2008-02-08       Impact factor: 3.533

Review 7.  PPARγ signaling and metabolism: the good, the bad and the future.

Authors:  Maryam Ahmadian; Jae Myoung Suh; Nasun Hah; Christopher Liddle; Annette R Atkins; Michael Downes; Ronald M Evans
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

8.  The effect of n-3 long chain fatty acids supplementation on plasma peroxisome proliferator activated receptor gamma and thyroid hormones in obesity.

Authors:  Parizad Taraghijou; Abdolrasoul Safaeiyan; Majid Mobasseri; Alireza Ostadrahimi
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

9.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23

10.  The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice.

Authors:  W Wallace Harrington; Christy S Britt; Joan G Wilson; Naphtali O Milliken; Jane G Binz; David C Lobe; William R Oliver; Michael C Lewis; Diane M Ignar
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.